Switching to Reduced Oxidant or Nicotine Content Cigarettes in Smokers
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The overall objectives of this clinical study are to determine in smokers the short term
effects of switching to tobacco products that deliver low levels of nicotine or reactive
oxygen/nitrogen species (ROS/RNS) on smoking behavior and biomarkers of tobacco smoke
exposure and oxidative stress.
Phase:
N/A
Details
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborators:
Food and Drug Administration (FDA) National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH)